Dr. Jay H. Lee, MD

Dr. Lee practices at Pavilion Surgery Center in Orange, California.

Dr. Lee's NPI, 1053346858, was assigned on July 11, 2006. Dr. Lee graduated from Keck School of Medicine of USC in 1995. Dr. Lee holds California license A63111.

Dr. Lee's primary practice is Pavilion Surgery Center, at 1140 West La Veta Ave, Suite 300, Orange, CA 92868. The practice phone is (949) 390-9656.

Dr. Lee's primary practice is Pavilion Surgery Center in Orange, California. Dr. Lee is also affiliated with Providence St. Joseph Hospital Orange. The medical group on file is Orange County Heart Institute. Dmand AI also links Dr. Lee to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Lee is board certified in cardiovascular disease by the National Board of Physicians and Surgeons. Dr. Lee is licensed in California.

Dmand AI lists atrial fibrillation and flutter, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Lee treats.

CMS data shows 4,773 Medicare services from Dr. Lee across 44 procedure codes in 2024, for 807 Medicare patients. Medicare paid $524,803 for them.

CMS counts 807 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 332 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 77, with 42% women.

In 2024, Dr. Lee wrote 4,631 Medicare Part D claims for 686 patients. 72% of them were for generic drugs. CMS names the drug for 4,474 of them, across 41 drugs with 11 or more claims each, at $1,444,059 in total drug cost. In 2023, CMS named 4,455 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Lee for performance year 2024, reported individually. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 40 procedures of pacemaker insertion or repair by Dr. Lee, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Lee, published from 2012 to 2024. Dr. Lee has published most often in Biotechnol Bioeng. Dr. Lee's most frequent co-authors are William I. Frumkin, MD, Michael C. Giudici, MD and Suresh B. Neelagaru, MD.

Dmand AI links Dr. Lee to 1 clinical trial. Conditions studied include Heart Failure and Heart Diseases.

CMS Open Payments shows 888 general payments to Dr. Lee from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Janssen Pharmaceuticals, Inc paid the most, $76,929.

Dmand AI lists 2 awards for Dr. Lee, most recently CMS Stage 1 2012 in 2012.

Dr. Lee graduated from Keck School of Medicine of USC in 1995. Dr. Lee is a member of ACC.

Dr. Lee is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.